REG - Oxford Instruments - Trading Statement <Origin Href="QuoteRef">OXIG.L</Origin>

Oxford InstrumentsAnnouncement

13/04/2017 07:01

RNS Number : 3855C
Oxford Instruments PLC
13 April 2017
Oxford Instruments plc
Trading Update 13 April 2017
Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, is today issuing a trading statement ahead of entering its close period.
Trading in the second half of the year was consistent with the expectations disclosed in our interim results, supporting our guidance that we expect performance for the full year to be in line with the prior year.
A good performance from NanoTechnology Tools has continued to mitigate an anticipated deterioration in our OI Healthcare business.
Our focus on strengthening the balance sheet has resulted in a reduction in net debt at 31 March 2017 against the same period last year.
Oxford Instruments' results for the year ended 31 March 2017 will be released on 13 June 2017. 
Enquiries:
Oxford Instruments plc   Tel: 01865 393200
Ian Barkshire, Chief Executive
Gavin Hill, Group Finance Director
MHP Communications Tel: 020 3128 8100
Rachel Hirst/Jamie Ricketts
- Ends -
Issued for and on behalf of Oxford Instruments plc
Notes to Editors
About Oxford Instruments plc
Oxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. Innovation has been the driving force behind Oxford Instruments' growth and success for over 50 years, and its strategy is to effect the successful commercialisation of these ideas by bringing them to market in a timely and customer-focused fashion.
The first technology business to be spun out fromOxfordUniversity, Oxford Instruments is now a global company and is listed on the London Stock Exchange (OXIG). Its objective is tobe the leading provider of new generation tools and systems for the research and industrial sectors with a focus on nanotechnology. Its key market sectors include nano-fabrication and nano-materials. The company's strategy is to expand the business into the life sciences arena, where nanotechnology and biotechnology intersect.
This involves the combination of core technologies in areas such as low temperature and high magnetic field environments; NuclearMagnetic Resonance; X-ray, electron, laser and optical based metrology; atomic force microscopy; optical imaging; advanced growth, deposition and etching.
Oxford Instruments aims to pursue responsible development and deeper understanding of our world through science and technology. Itsproducts, expertise, and ideas address global issues such as energy, environment, security and health. 

This information is provided by RNS
The company news service from the London Stock Exchange
  END
TSTDLLFFDZFFBBB